• Link to Facebook
  • Link to X
  • Link to Youtube
  • Link to LinkedIn
  • Link to Bluesky Link to BlueskyLink to Bluesky
  • Link to Instagram
  • ESO
  • ESOC 2026
  • ESOC 2027
  • STROKE INSIGHTS
  • eSTEP
  • MEMBERSHIP
  • SUPPORT US
THE VOICE OF STROKE IN EUROPE
European Stroke Organisation
  • About
    • What we do
    • Who we are
      • Leadership
      • ESO Committees
      • Honorary Members
      • Award Recipients & Awards Selection Committee
      • Young Stroke Physicians and Researchers Committee
      • DEI Advisory Council
      • Head Office
    • Membership
      • Benefits
      • Individual Membership
      • Organisational Membership
      • Membership Fees
    • Governance
      • Bylaws and Statues, Advocacy
      • Code of Conduct
    • History
    • Global Stroke Cooperation
  • Meetings
    • ESO Conference
    • ICH Academy Meeting (IAM)
    • Simulation Workshop 2026
    • Winter School
    • Summer School
    • Edinburgh Stroke Research Workshop
    • European Stroke Science Workshop
    • Focused Workshop
    • Educational Webinars
    • ESO Endorsed Meetings and Education
      • Applications for Endorsement
    • Events Calendar
  • Guidelines
    • ESO Guideline Directory
    • ESO Guideline Board
    • ESO Guideline Development Webinar
  • Projects
    • ANGELS
    • ESO EAST (Enhancing and Accelerating Stroke Treatment)
    • RES-Q — Registry of Stroke Care Quality
    • EU Research Partnerships
    • QASC
    • Stroke Action Plan for Europe (SAP-E)
    • Stroke Unit and Stroke Centre Certification
    • WISE
  • Resources
    • eSTEP
    • Emerging Leader Programme
    • European Master Programme in Stroke Medicine
    • Department to Department Visit Programme
    • ESO Trials Alliance
    • European Telestroke Networks
    • COVID-19 Resources
    • Task Force 4 Ukraine
  • News and Media
    • European Stroke Journal (ESJ)
    • Blog
    • Podcast
    • Paper of the Month
    • Press
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Transient Focal Neurologic Episodes and Cerebral Amyloid Angiopathy

10/02/2023/in ESO, Stroke Research /by Carine Legio

Author: Ana Ferreira Ponciano

Leiria Hospital Center, Portugal

Cerebral amyloid angiopathy (CAA) affects small arteries and arterioles of the cortex and leptomeninges. CAA is a common cause of lobar cerebral haemorrhage in elderly populations. However, recent research shows that CAA patients can also present with transient focal neurological episodes (TFNE), previously also called amyloid spells.1

The hallmark features of TFNE are recurrent and stereotyped neurological symptoms of brief duration, typically under 30 minutes. TFNEs usually present with a spreading progression of focal motor, somatosensory, visual, or language functions.2 Both positive and negative symptoms are equally common (52% vs 48%, respectively), the commonest positive symptom consisting of transient paraesthesia in the mouth or hand (32%), often but not always with a gradual spread to contiguous body parts. The negative symptoms included focal weakness and dysphasia.3

Advances in brain neuroimaging, especially MRI, allowed for further characterisation of haemorrhagic findings. TFNE’s are closely associated with convexity subarachnoid haemorrhage and cortical superficial siderosis. Cortical spreading depolarisation, also known as spreading depression, secondary to irritative blood products trapped within the cerebral sulcus is the most likely mechanism. This depolarisation propagates gradually across contiguous cortical regions, which explains the slow, smooth and somatotopic spread of neurological deficits that are a characteristic feature of TFNE’s. Nonetheless, the potential mechanism triggering cortical depolarisation remains to be demonstrated.3

Electroencephalography changes, such as intermittent focal slowing, were found in a subset of patients with TFNE, but it is not clear whether all TFNE presentations (for example, limb-jerking) can be explained by cortical spreading depression alone; seizure activity might play a role in some patients. Although there is increasing anecdotal data that antiepileptic and antimigraine medications (such as levetiracetam or topiramate) might reduce the frequency or severity of TFNE symptoms, they may also remit spontaneously. However, controlled trial data are lacking to further validate the use of antiepileptic therapy in this subset of patients.4

TFNE poses a common diagnostic challenge to physicians as it can be difficult to distinguish from transient ischaemic attacks or other transient neurologic syndromes such as migraine with aura, or focal seizures. Patients with TFNE are at substantial risk of subsequent lobar ICH that would be increased even further by prescription of antithrombotic medication in case of a presumed TIA. Performing MRI is therefore paramount in identifying imaging evidence of CAA when TFNE is suspected.1, 3


References:

  1. Viswanathan A, Greenberg SM. Cerebral Amyloid Angiopathy in the Elderly. Ann Neurol. 2011;70:871–880.
  2. Charidimou A. Cerebral amyloid angiopathy-related transient focal neurological episodes (CAA-TFNEs): A well- defined clinical-radiological syndrome. Journal of the Neurological Sciences. 2019; 406: 116496.
  3. Smith EE, Charidimou A, Ayata C, Werring DJ, Greenberg SM. Cerebral amyloid angiopathy-related transient focal neurologic episodes. Neurology. 2021;97(5):231-238.
  4. Banerjee G, Carare R, Cordonnier C, et al. The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice Neurol Neurosurg Psychiatry. 2017;88:982–994.

ESOC is Europe’s leading forum for advances in research and clinical care of patients with cerebrovascular diseases. ESOC 2023 will live up to its expectation, and present to you a packed, high quality scientific programme including major clinical trials, state-of-the-art seminars, educational workshops, scientific communications of the latest research, and debates about current controversies. ESOC 2023 programme is now available, and registration are now open.  Learn more here.

Recent Posts

  • Functional outcomes and quality of life after endovascular thrombectomy in large and extensive infarcts (ASPECTS 0–5): a multicentre registry study 13/11/2026
  • D2D Report – Michael Yirgalem Teka 06/11/2026
  • Train the Trainer workshop: learning to build our own stroke simulations 30/10/2026
  • Highlights from the 10th World Intracranial Hemorrhage Conference 23/10/2026
  • Beyond angiography: flat-panel imaging after thrombectomy 16/10/2026
  • D2D Report – Dimitar Mitsev 09/10/2026
  • The Expanding Role of Endovascular Therapy in Cerebral Venous Sinus Thrombosis 02/10/2026
  • ESJ Featured Article of the Month – September 2026: Anaesthesia during medium and distal vessel thrombectomy: a signal, not yet a strategy 25/09/2026
  • ESO TF4UKR D2D Report – Alina Trubetska 18/09/2026
  • Post-Stroke Complications 11/09/2026

Tags

2021 acute ischemic stroke brain cardiology career clinical D2D department to department visit emergency medicine ESJ ESO ESO-EAST ESOC ESOC 2018 ESOC 2019 ESOC 2022 ESOC 2023 ESOC 2024 ESOC 2025 ESOWSO2020 Europe European Stroke Journal FESO guidelines hospital interview ischaemic stroke ischemic stroke networking Neurology newsletter research SAFE stroke stroke care Stroke Center stroke in the young stroke research stroke treatment stroke trials TF4UKR TIA trials virtual YSPR

Archive

Categories

  • ESO
  • ESOC
  • IRT Post
  • Stroke Research

European Stroke Organisation
Reinacherstrasse 131
4053 Basel / Switzerland
E: esoinfo@eso-stroke.org

  • Home
  • ESO Conference
  • Blog
  • My ESO
  • Membership
  • Subscribe to our Newsletter
© ESO-STROKE 2024 — the Voice of Stroke in Europe
  • Link to Facebook
  • Link to X
  • Link to Youtube
  • Link to LinkedIn
  • Link to Bluesky Link to BlueskyLink to Bluesky
  • Link to Instagram
  • Imprint
  • Privacy Statement
  • Disclaimer
  • Contact
Scroll to top Scroll to top Scroll to top